1 May 2025

Last updated: Tuesday 29 April 2025

Research Directory

Antimicrobial Review: Drug-resistant infections are the silent pandemic

Obesity Review, New drugs and new indications in the clinic, by Peter Charlish

EU-wide health technology assessment to take effect

EU guides on the use of AI in medicines regulation

The weight loss sector continues to evolve

GLP-1 agonist shortages set to continue

More advanced planning needed for antimicrobials

New antibiotics pass regulatory hurdles

GLP-1 agonists shake up the sector

FDA guidance on drugs for early Alzheimer's disease